Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase as an Anticancer and Radiosensitizing Target

Title
Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase as an Anticancer and Radiosensitizing Target
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 16, Issue 3, Pages 814-824
Publisher
American Association for Cancer Research (AACR)
Online
2010-01-27
DOI
10.1158/1078-0432.ccr-09-1592

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now